The aim of this study was to evaluate the efficacy of treatment of @entity791 -related and non @entity791 -related @entity2826 ( @entity2826 ) using @entity5713 (Velb    ). A retrospective study was conducted between January 1990 and December 2009 in the Department of Dermatology at the Lom   teaching hospital. The therapeutic protocol is the administration of 10 injections of @entity5713 every 15 days. Evaluation was done at 10 weeks, 5 months, 11 months and 17 months. Twenty-three @entity1 including 11 cases of non @entity791 -related @entity2826 and 12 cases of @entity791 -related @entity2826 were included in our study. The average age of @entity1 was 39.3    11.2 years. The sex-ratio (M/F) was 6:7. At ten weeks, partial remission was 26% and failure rate was 74%. Side effects as a result of the first five injections were dominated by @entity417 . At 5 months, complete remission was 17% including 3 cases of non @entity791 -related @entity2826 , partial remission was 26% including 4 cases of non @entity791 -related @entity2826 . Side effects of the last five injections were dominated by @entity417 and @entity137 . At 11 months, one @entity1 was lost to follow-up and complete remission persisted in 13% of the @entity1 . At 17 months, complete remission persisted in 9% of the @entity1 against 4% of relapses. No long-term side effects were identified. Our study shows a poor efficacy of @entity5713 in the treatment of @entity791 -related and non @entity791 -related @entity2826 and confirms the hematologic and @entity137 of this drug. The efficacy is better in the non @entity791 -related @entity2826 than in the @entity791 -related @entity2826 .

[Evaluation of the treatment of @entity2826 with XXXX in Togo: a study of 23 cases].

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity2826 :: ('MESH:D012514', 'Disease') :: ["Kaposi's sarcoma", 'KS'] @entity137 :: ('MESH:D064420', 'Disease') :: ['nervous toxicity'] @entity417 :: ('MESH:D000740', 'Disease') :: ['anemia'] @entity791 :: ('MESH:D000163', 'Disease') :: ['AIDS'] @entity5713 :: ('MESH:D014747', 'Chemical') :: ['vinblastine']
@entity5713 :: (MESH:D014747,Chemical) :: ['vinblastine']
